As cardiovascular disease progresses, the issue of switching from one β blocker to another is an important consideration as to how to optimize the effectiveness of adrenergic blockade.
Remme WJ. β blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first? Cardiol. Clin. 25(4), 581–594 (2007). • Critical anaysis of the data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback